Piezo Motion Announces a Partnership to Expand Its Disruptive Precision Motor Technology
February 03, 2022 08:00 ET
|
Brain Scientific Inc.
LAKEWOOD RANCH, Fla., Feb. 03, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Piezo Motion, a Brain Scientific (OTCQB:BRSF) company, and Applied Mechatronics today announce a partnership. Piezo Motion...
Revolution Medicines to Provide R&D Update, Including Expansion of Development-Stage RAS(ON) Inhibitor Pipeline, During Presentation at 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022 07:30 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on developing targeted therapies for RAS-addicted...
Revolution Medicines to Participate in 4th Annual Evercore ISI HealthCONx Conference
November 24, 2021 07:30 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted drugs to inhibit...
Revolution Medicines to Participate in Stifel 2021 Virtual Healthcare Conference
November 08, 2021 16:05 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted drugs to inhibit...
Revolution Medicines to Report Financial Results for Third Quarter 2021 After Market Close on November 10, 2021
November 03, 2021 16:05 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted drugs to inhibit...
Phoenix Specialty Manufacturing Is Helping Customers Reduce Supply Chain Risk
October 07, 2021 13:00 ET
|
Phoenix Specialty Manufacturing Co.
BAMBERG, S.C., Oct. 07, 2021 (GLOBE NEWSWIRE) -- As the manufacturing supply chain continues to experience the pain associated with shipping delays, material shortages and significant inflation,...
Revolution Medicines to Participate in 3rd Annual RAS-Targeted Drug Development Summit
September 15, 2021 07:30 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted drugs to inhibit...
Revolution Medicines to Present at H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021 16:05 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted drugs to inhibit...
Revolution Medicines Reports Second Quarter Financial Results and Update on Corporate Progress
August 11, 2021 16:01 ET
|
Revolution Medicines, Inc.
Company Shows Continued Progress Demonstrating Differentiation of RAS(ON) Inhibitors, Targeting Additional RAS Variants and Progressing Assets Toward the Clinic Initial Results of RMC-4630-02 Study...
Revolution Medicines to Report Financial Results for Second Quarter 2021 After Market Close on August 11, 2021
August 04, 2021 16:05 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted drugs to inhibit...